Results 231 to 240 of about 125,630 (346)

Acute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Nonpuerperal uterine inversion (NPUI) due to endometrial carcinosarcoma can present in an acute manner with life‐threatening complications. The rare presentation of uterine inversion outside of the puerperium caused by a malignant etiology, which was further complicated by the urgent need for intervention, makes this case crucial in ...
Aman Kaur More, Sarah Louise Smyth, Ana Sofia Cerdeira, Hooman Soleymani majd   +3 more
wiley   +1 more source

Bladder masses simulating neoplasia in chronic granulomatous disease: Diagnostic challenges and spontaneous regression. [PDF]

Urol Case Rep
Dadpour M, Soleimanifard N, Alishah S, Chalaki M.   +3 more
europepmc   +1 more source

Pulmonary Tuberculosis: The Great Mimicker of Lung Cancer

Clinical Case Reports, Volume 14, Issue 2, February 2026.
Computed tomography (CT) scan of the chest with contrast indicating a soft tissue density in the left upper lobe. ABSTRACT Though tuberculosis (TB) is an ancient pathogen, diagnosis remains challenging. Distinguishing pulmonary tuberculoma, a rare manifestation of TB, from lung cancer is critical.
Laura Corrales‐Diaz Pomatto‐Watson, Hershan Singh Johl, Karleen Meiklejohn   +2 more
wiley   +1 more source

Case report: Radiographic and cystoscopic manifestations of chronic urogenital Schistosomiasis in an asymptomatic Zimbabwean man with HIV. [PDF]

Urol Case Rep
Kaur H, Alkayali T, Williams N, Schmalzle SA.   +3 more
europepmc   +1 more source

Primary Neoplasms of the Urinary Bladder

, 1928
E. J. Boardman
openalex   +1 more source

Event‐free survival and complete response rate as surrogate endpoints for overall survival in high‐risk non–muscle‐invasive bladder cancer: A meta‐analysis of bacillus Calmette‐Guérin—naive or —remote cases

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Event‐free survival (EFS) and complete response rate (CRR) are recommended as primary endpoints in bladder cancer trials to enable timely assessment of therapeutic benefit. However, their surrogacy relationship with overall survival (OS) in high‐risk non–muscle‐invasive bladder cancer (HR NMIBC) remains unclear.
Rituparna Bhattacharya, Kalé Kponee‐Shovein, Yipeng Gao, Yan Song, Jingyi Liu, Katherine Wei, Ekta Kapadia, Haojie Li, Ashish M. Kamat   +8 more
wiley   +1 more source

Recurrent bladder paraganglioma with peritoneal dissemination: An unusual pattern of metastatic progression. Case report and literature review. [PDF]

Urol Case Rep
Oliva PG, Marrero PJ, Espino RE, Marrero Domínguez R, Expósito Remedios I, Galán RC.   +5 more
europepmc   +1 more source

Minimal residual disease in solid tumors: Clinical applications and future directions

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo, Ahmad Alhalabi, Sacha Yaghi, Mohammad Aloran, You Li, María Herrán, Rami Tfayli, Thomas A. Samuel, Zeina Nahleh   +8 more
wiley   +1 more source

Human papillomavirus type 16 and 18 in urothelial bladder neoplasms: detection, quantification, and comparison with non-neoplastic samples. [PDF]

Infect Agent Cancer
Yazdani A, Kamrani G, Shiadeh AE, Moudi E, Vosough Z, Shirafkan H, Sadeghi F, Hosseini A.   +7 more
europepmc   +1 more source

A STUDY OF P53 EXPRESSION IN UROTHELIAL NEOPLASMS OF URINARY BLADDER

, 2017
Sathish Kumar G, Haris C.H
openalex   +1 more source